Search

everythinglearnresearchcommunity

for

Search:↓

A certain medication improved severe itching in a boy with liver and bowel disease by reducing histamine levels, suggesting a new treatment target.

Certain drugs can cause eyelid inflammation, so doctors should monitor and educate patients on eyelid care.

Finasteride reduces movement issues in Parkinson's disease rats.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

Combination drug therapies are more effective for high-risk BPS patients but have more side effects and costs.

New treatments for enlarged prostate are being developed to be more effective and have fewer side effects.

Tadalafil is effective for treating urinary symptoms in men with BPH.

RY-023, a specific drug, can improve early stage memory learning without affecting general activity in rats, but it's less effective for later learning stages and doesn't impact memory recall.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Certain derivatives are more effective 5α-reductase type 2 inhibitors than finasteride.

Benzo[c]quinolizin-3-ones are effective nonsteroidal inhibitors of human steroid 5α-reductase 1.

Botox is effective for urinary incontinence, chronic migraines, and male pattern hair loss, and a new test for Botox antibodies is more humane.

Changing the C-ring structure in certain compounds can make them better at blocking a specific human enzyme.

New chemical compounds were made that effectively block an enzyme linked to prostate growth.

New compounds called benzoquinolinones may treat conditions linked to excess DHT.

5-Alpha reductase inhibitors help treat enlarged prostate but may cause sexual side effects.

Combination therapy with fesoterodine and doxazosin improves bladder function and delays BPH progression.

Finasteride helps improve treatment for benign prostatic hyperplasia.

Alpha-blockers and 5-alpha reductase inhibitors are main treatments for BPH, with new support for phosphodiesterase-5 inhibitors and beta-3 agonists.

Polygoni Cuspidati Rhizoma et Radix contains compounds that inhibit certain enzymes.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

EETs can delay seizures by affecting GABA activity, offering potential new treatments for seizures.

Finasteride may help reduce symptoms in male Tourette syndrome patients.

Botulinum neurotoxin A is effective and safe for treating various conditions, but more clinical trials are needed to fully assess its benefits and risks.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

Modified steroidal inhibitors showed promise in treating hormone-dependent cancers.

Steroid sulfatase inhibitors could help treat hormone-related disorders and cancers.

In 2002, various drugs caused serious side effects, including vitamin B12 deficiency, heart issues, blindness, hypersexuality, allergic reactions, blood clotting problems, pupil dilation, capillary leak syndrome, muscle breakdown, hepatitis, skin reactions, and lupus.